FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2302221159> ?p ?o ?g. }

• W2302221159 endingPage "55" @default.
• W2302221159 startingPage "55" @default.
• W2302221159 abstract "Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial Ida Unhammer Njerve,1–3 Rune Byrkjeland,1–3 Harald Arnesen,1–3 Sissel Åkra,1,2 Svein Solheim,1,2 Ingebjørg Seljeflot1–3 1Department of Cardiology, Center for Clinical Heart Research, Oslo University Hospital, Ullevål, 2Center for Heart Failure Research, Oslo University Hospital, 3Faculty of Medicine, University of Oslo, Oslo, Norway Purpose: Adipose tissue inflammation plays a role in atherosclerosis and type 2 diabetes (T2DM). We aimed to investigate whether 12 months of exercise training in patients with both T2DM and coronary artery disease (CAD) reduced the genetic expression of the proinflammatory markers fractalkine (CX3CL1) and its receptor (CX3CR1) and monocyte chemoattractant protein-1 (MCP-1) in the subcutaneous adipose tissue. Expression of the genes in the circulating leukocytes and circulating levels of the markers were also investigated. Patients and methods: A total of 137 patients with T2DM and CAD were included to study the effects of exercise on atherosclerosis progression and glucose control. Patients were randomized to exercise training (combined aerobic and strength training) or control. At inclusion and after 12 months, fasting blood samples and a subcutaneous adipose tissue sample were taken. RNA was extracted from the adipose tissue and circulating leukocytes, and the expression levels were examined by reverse transcription-polymerase chain reaction. Circulating fractalkine and MCP-1 were determined by enzyme-linked immunosorbent assay. Results: The analyses were performed in 114 patients who completed the study and adhered to the intervention principle. At baseline, gene expression of fractalkine and CX3CR1 in the adipose tissue was similar in the two groups. There were no change within either group and no between-group differences in changes from baseline. Circulating fractalkine increased after 12 months in the exercise group (P=0.044), significantly more compared to controls (P=0.042), however only in the patients with advanced vascular disease. Neither the expression levels of MCP-1 nor the circulating levels changed significantly in either group. At baseline, CX3CR1 expression in the adipose tissue was associated with body mass index (P<0.001). Conclusion: No significant effects of long-term exercise training on adipose tissue expression of fractalkine, CX3CR1, or MCP-1 were found in our patients with combined CAD and T2DM. However, a slight increase in circulating fractalkine after the intervention was recorded. The association of CX3CR1 expression with body mass index might indicate increased immune activation in the adipose tissue. Keywords: diabetes, coronary artery disease, subcutaneous adipose tissue, exercise, MCP-1, fractalkine (CX3CL1)" @default.
• W2302221159 created "2016-06-24" @default.
• W2302221159 creator A5006868417 @default.
• W2302221159 creator A5013183670 @default.
• W2302221159 creator A5055382477 @default.
• W2302221159 creator A5057514868 @default.
• W2302221159 creator A5072637485 @default.
• W2302221159 creator A5084461040 @default.
• W2302221159 date "2016-03-01" @default.
• W2302221159 modified "2023-10-14" @default.
• W2302221159 title "Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial" @default.
• W2302221159 cites W1505051310 @default.
• W2302221159 cites W1957769650 @default.
• W2302221159 cites W1967161323 @default.
• W2302221159 cites W1969118157 @default.
• W2302221159 cites W1976125614 @default.
• W2302221159 cites W1984115097 @default.
• W2302221159 cites W2008869160 @default.
• W2302221159 cites W2010052806 @default.
• W2302221159 cites W2027530704 @default.
• W2302221159 cites W2067359474 @default.
• W2302221159 cites W2076633494 @default.
• W2302221159 cites W2084104194 @default.
• W2302221159 cites W2094170218 @default.
• W2302221159 cites W2098946775 @default.
• W2302221159 cites W2100573896 @default.
• W2302221159 cites W2103018133 @default.
• W2302221159 cites W2107277218 @default.
• W2302221159 cites W2107366236 @default.
• W2302221159 cites W2110335402 @default.
• W2302221159 cites W2111106822 @default.
• W2302221159 cites W2120638415 @default.
• W2302221159 cites W2124620553 @default.
• W2302221159 cites W2127072581 @default.
• W2302221159 cites W2136956402 @default.
• W2302221159 cites W2137304414 @default.
• W2302221159 cites W2147181044 @default.
• W2302221159 cites W2154722437 @default.
• W2302221159 cites W2157321333 @default.
• W2302221159 cites W2159054424 @default.
• W2302221159 cites W2162107224 @default.
• W2302221159 cites W2164285684 @default.
• W2302221159 cites W2192080449 @default.
• W2302221159 doi "https://doi.org/10.2147/dmso.s96299" @default.
• W2302221159 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4798200" @default.
• W2302221159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27042130" @default.
• W2302221159 hasPublicationYear "2016" @default.
• W2302221159 type Work @default.
• W2302221159 sameAs 2302221159 @default.
• W2302221159 citedByCount "6" @default.
• W2302221159 countsByYear W23022211592018 @default.
• W2302221159 countsByYear W23022211592020 @default.
• W2302221159 countsByYear W23022211592021 @default.
• W2302221159 countsByYear W23022211592022 @default.
• W2302221159 crossrefType "journal-article" @default.
• W2302221159 hasAuthorship W2302221159A5006868417 @default.
• W2302221159 hasAuthorship W2302221159A5013183670 @default.
• W2302221159 hasAuthorship W2302221159A5055382477 @default.
• W2302221159 hasAuthorship W2302221159A5057514868 @default.
• W2302221159 hasAuthorship W2302221159A5072637485 @default.
• W2302221159 hasAuthorship W2302221159A5084461040 @default.
• W2302221159 hasBestOaLocation W23022211591 @default.
• W2302221159 hasConcept C126322002 @default.
• W2302221159 hasConcept C13373296 @default.
• W2302221159 hasConcept C134018914 @default.
• W2302221159 hasConcept C164705383 @default.
• W2302221159 hasConcept C168563851 @default.
• W2302221159 hasConcept C171089720 @default.
• W2302221159 hasConcept C2776914184 @default.
• W2302221159 hasConcept C2777180221 @default.
• W2302221159 hasConcept C2778213512 @default.
• W2302221159 hasConcept C555293320 @default.
• W2302221159 hasConcept C71924100 @default.
• W2302221159 hasConceptScore W2302221159C126322002 @default.
• W2302221159 hasConceptScore W2302221159C13373296 @default.
• W2302221159 hasConceptScore W2302221159C134018914 @default.
• W2302221159 hasConceptScore W2302221159C164705383 @default.
• W2302221159 hasConceptScore W2302221159C168563851 @default.
• W2302221159 hasConceptScore W2302221159C171089720 @default.
• W2302221159 hasConceptScore W2302221159C2776914184 @default.
• W2302221159 hasConceptScore W2302221159C2777180221 @default.
• W2302221159 hasConceptScore W2302221159C2778213512 @default.
• W2302221159 hasConceptScore W2302221159C555293320 @default.
• W2302221159 hasConceptScore W2302221159C71924100 @default.
• W2302221159 hasLocation W23022211591 @default.
• W2302221159 hasLocation W23022211592 @default.
• W2302221159 hasLocation W23022211593 @default.
• W2302221159 hasLocation W23022211594 @default.
• W2302221159 hasLocation W23022211595 @default.
• W2302221159 hasOpenAccess W2302221159 @default.
• W2302221159 hasPrimaryLocation W23022211591 @default.
• W2302221159 hasRelatedWork W106298747 @default.
• W2302221159 hasRelatedWork W1990952279 @default.
• W2302221159 hasRelatedWork W2120251679 @default.
• W2302221159 hasRelatedWork W2129686792 @default.
• W2302221159 hasRelatedWork W2143040158 @default.
• W2302221159 hasRelatedWork W2143690397 @default.
• W2302221159 hasRelatedWork W2382805495 @default.

• next